BIOTE ($BTMD) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of $0.08 per share, beating estimates of $0.07 by $0.01. The company also reported revenue of $48,990,000, beating estimates of $48,193,470 by $796,530.
You can see Quiver Quantitative's $BTMD stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIOTE Insider Trading Activity
BIOTE insiders have traded $BTMD stock on the open market 18 times in the past 6 months. Of those trades, 18 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $BTMD stock by insiders over the last 6 months:
- LLC GUINES has made 13 purchases buying 1,104,096 shares for an estimated $3,590,191 and 0 sales.
- MARC D BEER purchased 107,794 shares for an estimated $417,162
- ANDREW R HEYER has made 2 purchases buying 75,000 shares for an estimated $296,042 and 0 sales.
- STEPHEN MARK CONE purchased 38,104 shares for an estimated $147,843
- BRET CHRISTENSEN (Chief Executive Officer) purchased 37,595 shares for an estimated $145,492
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BIOTE Hedge Fund Activity
We have seen 48 institutional investors add shares of BIOTE stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KANEN WEALTH MANAGEMENT LLC removed 289,803 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $965,043
- HILLSDALE INVESTMENT MANAGEMENT INC. added 252,544 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,560,721
- SW INVESTMENT MANAGEMENT LLC removed 200,000 shares (-40.0%) from their portfolio in Q4 2024, for an estimated $1,236,000
- LOS ANGELES CAPITAL MANAGEMENT LLC added 189,305 shares (+inf%) to their portfolio in Q1 2025, for an estimated $630,385
- ACADIAN ASSET MANAGEMENT LLC added 160,688 shares (+35.8%) to their portfolio in Q4 2024, for an estimated $993,051
- UBS GROUP AG added 96,894 shares (+1394.0%) to their portfolio in Q4 2024, for an estimated $598,804
- MARSHALL WACE, LLP added 87,913 shares (+inf%) to their portfolio in Q4 2024, for an estimated $543,302
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
BIOTE Analyst Ratings
Wall Street analysts have issued reports on $BTMD in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cowen & Co. issued a "Buy" rating on 11/14/2024
To track analyst ratings and price targets for BIOTE, check out Quiver Quantitative's $BTMD forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
